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An automated method for analyzing free non-cholesterol sterols in human serum using online solid
phase extraction–liquid chromatography–mass spectrometry is proposed herein. The method allows the
determination of three phytosterols (sitosterol, stigmasterol and campesterol) and two cholesterol
precursors (desmosterol and lanosterol). The analysis of sterols in human serum is critical in the study of
cholesterol-related disorders, such as inherited familial hypercholesterolemias. Special effort was made
to isolate the analytes from the serum lipoproteins, their natural conveyance through the bloodstream.
The sample treatment consisted of a Bligh–Dyer extraction followed by dilution of the extract. This
treatment allowed the sample to be injected into the online system and ensured the correct detection of
the analytes, while avoiding the matrix effects commonly related to serum samples.
The analytical performance showed linear ranges that covered two orders of magnitude, with
correlation coefficients above 0.99. Limits of detection and quantification ranged from 0.2 ng/mL to
13 ng/mL and from 1.0 ng/mL to 43 ng/mL, respectively. Recovery when spiking serum with a half or a
tenth of the average concentration reported in human serum ranged from 99% to 111% and from 102% to
120%, respectively. Intra-day precision and inter-day precision were below 20%.
& 2014 Published by Elsevier B.V.
1. Introduction
Sterols are metabolites related to cholesterol metabolism. The
analysis of these compounds in human serum is an essential step in
the diagnosis of cholesterol-related disorders, such as inherited
familial hypercholesterolemias, cerebrotendinous xanthomatosis
and sitosterolemia [1]. Cholesterol and related sterols are regulated
in the human body via a complex set of mechanisms. Cholesterol
can be absorbed through diet at intestinal level [2]. The rate of
cholesterol consumption can be inferred from the presence of
phytosterols such as sitosterol, stigmasterol and campesterol in
human serum, since they undergo the same absorption and secre-
tion processes [3]. Cholesterol is also endogenously produced and
regulated in the liver. Some sterols such as desmosterol and
lanosterol are intermediate products (precursors) in this reaction
mechanism. Since these compounds leak into the bloodstream at a
rate proportional to their formation in the cholesterol synthetic
pathway, the circulating levels of these endogenous precursors
reflect the rate of cholesterol synthesis [4,5].
Sterols have a non-polar structure and are carried through the
circulatory system by lipoproteins. Lipoproteins are aggregates of
lipids surrounded by a 2-nm amphiphilic layer composed of
phospholipids, apoproteins and free cholesterol [6]. Therefore,
the analysis of sterols involves the breakage of these aggregates.
The extraction of sterols has been typically performed using the
Bligh–Dyer method [7,8], where a mixture of chloroform and
methanol solubilizes the lipids from the lipoproteins, allowing the
apoproteins to be separated. Sterols have been traditionally analyzed
using gas chromatography, via a time-consuming derivatization step
[4,9–11]. Liquid chromatography (LC) coupled to mass spectrometry
(MS) avoids this derivatization step, diminishing the sample proces-
sing time [8,12]. However, the sample cleanup prior to LC–MS
analysis is still strongly recommended and a solid phase extraction
(SPE) step is generally performed [8,13].
An interesting choice is the use of hyphenated techniques that
couple SPE to LC–MS using a switching valve, which is common in
the analysis of biological samples and enables rapid and reliable
sample preparation [14–17]. Several publications dealing with online
systems are focused on determining drugs in plasma or urine; but
scarce literature has been found related to the determination of
endogenous metabolites [18,19]. A previous work of the authors
aimed at the reduction of the sample processing time for determin-
ing free and bonded sterols in human serum [20,21] and another
contribution demonstrated the capacity of coupling a Restricted
Access Material (RAM) cartridge to LC–MS for determining bile acids
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in human serum [22]. To the best of our knowledge, there is not such
a system to determine sterols in human serum, so the present
contribution aims at the routine analysis of sterols in a faster way by
using an online system.
2. Materials and methods
2.1. Chemicals and reagents
The sterols under study (Fig. 1) were provided by Sigma-Aldrich
(Madrid, Spain): desmosterol (purity 85%, Chemical Abstract Service
identification number: 303-04-2), campesterol (65%, 474-62-4),
stigmasterol (95%, 83-48-7), lanosterol (97%, 79-63-0), sitosterol
(95%, 83-46-5), and cholesterol-26,26,26,27,27,27-D6 (internal stan-
dard, IS, 97%, 60816-17-3). The solvents used were methanol
(supragradient LC–MS grade, 67-56-1), 2-propanol (LC–MS grade,
67-63-0), and chloroform (HPLC grade, 67-66-3). The solvents were
supplied by Sharlab (Barcelona, Spain). Water was obtained from a
Milli-Q Plus 186 device from Millipore (Billerica, MS, USA).
Stock solutions of 1000 mg/L in methanol were prepared for
each analyte. A stock solution of the IS at 100 mg/L was prepared in
2-propanol. A working solution with all of the sterols in methanol,
at a concentration of approximately 10 mg/L, was prepared and
stored in the dark at 4 1C.
2.2. Pooled serum
The pool of serum was obtained by mixing individual serum
samples from 150–200 informed healthy volunteers. The pool was
provided by the Lipids Unit of the Aragon Institute of Health Sciences
(Zaragoza, Spain), and stored in the dark at 80 1C prior to the analysis.
2.3. Sample preparation
The sample was prepared using the following method: 300 mL of
serum were extracted through a modification of the Bligh–Dyer
method [23]. A volume of 1 mL of chloroform–methanol (1:2, v/v)
was mixed with 30 mL of the IS solution and then added to the
serum. The mixture was then centrifuged at 9000 rpm (7500g)
for 10 min in a Microfuges 18 Centrifuge, Beckman Coulter™ (Brea,
CA, USA). The lower organic phase was recovered using a glass
Pasteur pipet and transferred to a 2-mL vial. The extract was then
accurately weighed, and 1 mL of methanol was added. The resulting
extract was filtered using a 0.22-mm Nylon syringe filter. After this
sample treatment, the final serum sample extract was ready to be
injected into the online system described below.
Fig. 2 illustrates the online system. The mobile phases were
delivered using three pumps; a 600E Controler Multisolvent Deliv-
ery System (pump 1) with a 717 plus Autosampler (Waters, Milford,
MS, USA), a Kontron 322 System auxiliary binary pump (Kontron
Instruments, Neufahrn, Germany) (pump 2) and an Alliances 2795
Separations Module (Waters) (pump 3). The fluidic paths were
controlled using a Cheminert C72 1690ED 10-port valve con-
trolled by microelectric actuators, purchased from VICIs Valco
Instruments (Houston, TX, USA). The analytes were detected using
a Quattro micro™ API Mass Spectrometer (Waters). All these
instruments were connected to operate simultaneously. This is
explained in detail in the Supplementary information section S1.
Table 1 shows the steps of the online method, flow rate and
composition of pumps 1 and 3, as well as the valve position
program. The online method comprises four steps: loading, wash-
ing, eluting and detection.
For loading, 300 mL of the treated serum were injected using the
717 plus Autosampler and transferred to a 204 mm BioTrap 500C18
cartridge, supplied by ChromTech Ltd. (Cheshire, UK) at a 2.0 mL/min
flow of 60% methanol and 40% water. A 2-mm filter was included
before the cartridge to prevent clogging. This step lasted 4 min.
The washing step consisted of a 2.0 mL/min flow of water. The
elution of large, non-retained molecules was monitored at 220 nm
using a 2487 dual λ absorbance detector (Waters). Their elimination
was considered to be complete when the UV signal had fallen below
0.05 absorbance units. Then, the valve was automatically switched to
the eluting position.
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2.4.3. Elution
From min 9 to 35, the retained compounds were backflushed from
the cartridge using 2-propanol at a flow rate of 0.4 mL/min. Before
entering the analytical column, a water cross-flow of 0.6 mL/min was
added (pump 2), leading to a total flow of 1 mL/min of 60% water and
40% 2-propanol. This flow composition ensured that the sterols were
retained at the head of the analytical column.
2.4.4. Detection
The analytes were separated using an XTerras MS C18 column
(4.6100 mm and 3.5 mm particle size, Waters). A guard column of
the same stationary phase material and 5 mm particle size was used to
protect the analytical column. The column temperature was set at
60 1C. The analytical gradient started at 35 min, using an 85%
methanol and 15% water, at a flow rate of 0.7 mL/min. Then, the
gradient was increased in 9 min to 100% methanol, where it was held
for 5 min. The last compound (sitosterol) was eluted after 13.8 min of
chromatography.
The compounds of interest were determined using atmospheric
pressure chemical ionization (APCI) detecting in positive mode.
The detection parameters were as follows: corona current, 10 mA;
source temperature, 130 1C; desolvation temperature, 600 1C and
desolvation nitrogen flow, 600 L/h. The optimized cone voltage was
þ20 V for all the compounds. The chromatograms were registered in
selected ion monitoring (SIM) mode. The protonated molecules (m/z)
of the target analytes are listed in Table 2. MassLynx v4.1 software
from Waters was used to acquire and process the generated data.
Complementary information dealing with the steps of the online
system can be found in the Supplementary information, section S2.
2.5. Evaluation of the method performance
The following analytical parameters were studied: calibration
curve, limits of detection (LODs) and quantification (LOQs), linear
dynamic range, recovery and reproducibility. The linear dynamic
range was determined from the response of nine standard solu-
tions spiked with the IS (30 mL of a 100 mg/L 2-propanol solution).
The calibration curve was prepared in a 1:2 (v/v) chloroform:
methanol solution, coinciding with the composition of the result-
ing mixture after the sample treatment. These solutions were
injected into the system in triplicate. The LOD and LOQ were
calculated as three and ten times the standard deviation of the
area of the peaks detected, respectively, when processing blank
samples (chloroform–methanol, 1:2 v/v). The determination of the
intra-day precision (n¼5), the inter-day precision (n¼3) and the
recovery was carried out by analyzing serum spiked at two
concentration levels: half and a tenth of the average concentration
of sterols according to the Human Metabolome Database [24].
Matrix effects were investigated by a post-extraction addition
experiment, as explained by Trufelli et al. [25]. Four sets of
samples were analyzed: a standard solution with a known con-
centration of the analytes (set A), serum samples spiked with the
same amount of analytes after the sample treatment (set B), serum
samples spiked with the same amount of analytes before the
sample treatment (set C) and serum samples non-spiked (set D)
to subtract the endogenous concentration levels. The response of
the analytes was used in the following equations to quantify the
matrix effects (Eq. (1)), the extraction recovery (Eq. (2)) and the
process efficiency (Eq. (3)).
Matrix effects %ð Þ ¼ 100 BDð Þ
A
ð1Þ
Extraction recovery %ð Þ ¼ 100 CDð ÞðBDÞ ð2Þ
Process efficiency %ð Þ ¼ 100 CDð Þ
A
ð3Þ
3. Results and discussion
3.1. Sample treatment
The Bligh–Dyer method [26] is commonly used with human
serum samples to extract the lipids and remove the protein
fraction due to sterols are carried through the bloodstream by
lipoproteins [7,8]. For this reason, protein precipitation approach,
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Fig. 2. SPE–LC–MS flowchart scheme. (A) Loading and detection steps. (B)
Eluting step.
I. Mendiara et al. / Talanta ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 3
Please cite this article as: I. Mendiara, et al., Talanta (2014), http://dx.doi.org/10.1016/j.talanta.2014.10.029i
results in the undesirable precipitation of the lipoproteins and the
subsequent loss of the analytes (Fig. S3). Thus, a lipid extraction
step is essential to determine sterols even when using an online
system.
The composition of the final organic phase is mainly chloro-
form, which is not miscible with water and is not suitable for
direct injection in reversed-phase liquid chromatography. Thus,
the extract needs to be dried and reconstituted in a compatible
solvent [8]. The aim of the sample treatment was to obtain a final
extract suitable to be directly injected into the system. Herein, we
took advantage of the miscibility properties of the water–metha-
nol–chloroform tertiary system (as the Bligh–Dyer method does).
First, the composition of the initial mobile phase in the online
system was adjusted by increasing the proportion of methanol to
the maximum that still allows the analytes to be retained in the
C18 SPE cartridge, which is 60% methanol and 40% water. Next, the
extract was diluted using methanol in such a way that the mixture
with the initial composition of the mobile phase gives a single
liquid phase. Fig. S4 shows the composition of the extract along
the sample treatment in a ternary diagram for methanol–water–
chloroform mixtures.
3.2. Online system setup
3.2.1. Loading and washing steps
In the loading step, the analytes were injected and taken to a C18
SPE cartridge. The strong non-polar properties of sterols permitted
the use of C18 cartridges to concentrate them, while other less non-
polar compounds (even lipids) were eluted to waste.
The solvent used in the washing step was water. This solvent
showed satisfactory results removing interferences in a previous
work [20].
3.2.2. Elution step and water cross-flow
Preliminary tests showed that 2-propanol was a powerful
solvent for recovering the sterols from a C18 SPE cartridge. The
elution profile was determined by collecting 0.4-mL fractions from
the SPE cartridge in backflush mode every minute for 40 min. The
fractions were later analyzed by direct flow-MS (i.e. without using
the analytical column) in full-scan mode from 340 to 400 Da. In
this way, each fraction appeared as a single peak (Fig. S5). As can
be seen, 10 mL (25 fractions0.4 mL/fraction) of 2-propanol
quantitatively recovered the analytes from the cartridge. Thus,
the eluting stage lasted from 9 min to 35 min.
Because the cartridge and the analytical column were C18, the
designed system did not have truly orthogonal features. This means
that the eluting strength of 2-propanol would prevent the retention
of the analytes in the head of the analytical column, compromising
the chromatographic step. This problem was overcome by adding
water to the 2-propanol eluent after the cartridge. To find out the
necessary amount of water required to reduce the eluotropic
strength of the flow, the following experiment was carried out. A
standard solution of 1 mg/mL of sterols was prepared in 2-propanol.
Increasing volumes of water were added to 1 mL of the standard
solution and the resulting solutions were manually injected into the
LC–MS, using an auxiliary sample loop and the MS divert valve.
Fig. 3 shows how the added water reduced the eluotropic strength
of the solution, enabling the chromatographic process. From these
results, it was concluded that the flow composition entering the
column should contain at least 60% (v/v) water.
A flow of 40% 2-propanol and 60% water (v/v) produced high
backpressure in the analytical column. Hence, the total flow rate
entering the column was cut back to 1.0 mL/min (working back-
pressure of 200 bar), 0.4 mL/min of 2-propanol were used to back-
flush the analytes from the cartridge and 0.6 mL/min water cross
flow was added to reduce the eluotropic strength of the eluent.
3.3. Detection step
Sterols were detected in SIM mode as [MþHH2O]þ , which
corresponds to the loss of the hydroxy group as a molecule of
water (Table 2). This is commonly observed in the chemical
ionization of alcohols [27]. Sterols crashed into several daughter
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Table 1
SPE and LC mobile phase flow rates, composition and 10-port switching valve position program. The shaded cells correspond to flows that do not carry analytes; but
condition the path for the following injection.
Step Time
(min)
Valve
position
Flow through the SPE cartridge
(Pump 1)
Flow through the analytical column
(Pump 3)
Flow rate (mL/min)
Methanol water (60/40)
(%)
Water
(%)
2-Propanol
(%)
Flow rate (mL/
min)
Methanol
(%)
Water
(%)
Loading 0 A 2.0 100 0 0 0.3 0 0a
Washing 4 2.0 0 100 0 0.3 100 0
Eluting 9 B 0.4 0 0 100 1.0 0 100
Detectionb 0 A 0.4 0 0 100 0.7 85 15
9 0.4 100 0 0 0.7 100 0
14 0.4 100 0 0 0.7 100 0
a From min 0 to 4, the composition was 100% 2-propanol (see section S2).
b Time of the chromatographic separation.
Table 2
Detection parameters, linear dynamic range and limits of detection and quantification of the analysis of sterols by the proposed online SPE–LC–MS method.
Sterol CAS
numbera
Retention time
(min)
m/z Linear dynamic range (lg/
mL)
Correlation
coefficient
LOD (ng/
mL)
Concentration in pooled serum
(lg/mL)
Desmosterol 303-04-2 11.2 367.5 0.017–2.70 0.991 5.0 17 0.8370.23
Lanosterol 79-63-0 12.9 409.5 0.001–0.527 0.999 0.2 1.0 0.1770.04
Stigmasterol 83-48-7 13.0 395.5 0.025–5.22 0.994 7.5 25 1.3570.42
Campesterol 474-62-4 13.1 383.5 0.025–9.27 0.990 7.5 25 1.4970.26
Sitosterol 83-46-5 13.8 397.5 0.043–7.03 0.999 13 43 1.2870.07
a Chemical Abstract Service identification number.
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ions when the Multiple Reaction Monitoring (MRM) detection
mode was selected (even when using soft collision voltages). The
signal/noise values obtained in SIR mode were much higher than
those of the MRM mode. In this case, the selectivity provided by
the MRM mode was not enough to make up for the loss of
sensitivity.
3.4. Cross contamination
The Bligh–Dyer extraction method is intended for removing
proteins and simultaneously extracting lipids from blood and
other tissues, so it is not sterol-selective. During the development
of the method, cross-contamination was detected (blank injections
with ghost peaks). Phospholipids and triacylglycerols usually build
up in analytical or guard columns, especially when using aqueous
mobile phases [28]. This problem was solved by extending the
chromatographic gradient for 5 min after the elution of the last
compound. Fig. S6 shows the improvement when a column
cleaning step with 2-propanol was included. This is consistent
with Ismaiel et al., who found that 35% of 2-propanol in the mobile
phase was essential to elute lipids from the C18 guard column [28].
3.5. Evaluation of the method performance
One of the major drawbacks in biological analysis is the presence of
matrix effects, which affect the recoveries, quantitative performance
and the efficiency of the analytical process [15,25,29]. Hence, verifying
the absence of matrix effects is advisable. In accordance with Trufelli
et al. [25], post-extraction addition experiments were performed to
evaluate matrix effects, extraction recovery and process efficiency.
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Fig. 3. Study of the eluotropic strength of the flow to be transferred to the LC analytical column. Increasing the ratio 2-propanol/water led to a weaker initial mobile phase.
The chromatographic process was possible with at least 1.5 times more of water than 2-propanol.
Table 3
Recovery, intra- and inter-day precision of the analysis of sterols by the proposed online SPE–LC–MS method.
Sterol Spiked concentration (ng/
mL)
Calculated concentration (mean7std deviation,
ng/mL)
Recovery
(%)
Intra-day precision (RSD %,
n¼5)
Inter-day precision (RSD %,
n¼3)
Desmosterol 205 210712 102 6 12
42 4775 112 10 18
Lanosterol 38 4276 111 10 16
10 1273 120 15 20
Stigmasterol 398 403712 101 7 10
76 8079 105 11 14
Campesterol 736 73077 99 5 13
154 15779 102 12 19
Sitosterol 440 448710 102 4 15
87 9276 106 11 17
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Matrix effects ranged from 89% (stigmasterol) to 106% (lanos-
terol). This means that the signals observed were slightly affected by
other compounds coming from the sample. Thus, there were almost
no losses during the sample treatment. Finally, the process efficiency
was also determined. The values obtained ranged from 90% (stig-
masterol and campesterol) to 99% (desmosterol or lanosterol). These
results showed that matrix effects do not hinder the determination
of sterols via the proposed method. Since the response of the spiked
samples was similar to the response of the sterol standard solution,
an external calibration could be performed without applying a
matrix matched calibration or standard additions.
3.6. Analytical features
The following analytical parameters were determined: linear
dynamic range, LODs and LOQs, recovery, intra-day precision and
inter-day precision. The results related to the linear dynamic range,
limits of detection and quantification are listed in Table 2. Calibra-
tion was performed by plotting the ratio of the signal of the analyte
and the deuterated IS versus the ratio of \the concentrations. The
calibration curves were linear to two orders of magnitude with
correlation coefficients that ranged from 0.990 (campesterol) to
0.999 (sitosterol or lanosterol). The LOD ranged from 0.2 ng/mL
(lanosterol) to 13 ng/mL (sitosterol), and the LOQ ranged from
1.0 ng/mL (lanosterol) to 43 ng/mL (sitosterol). All of them were
low enough to analyze the sterols in human serum.
Recovery and reproducibility (intra-day precision and inter-day
precision) were evaluated by spiking the serum samples with
standard solutions as it is described in Section 2.5. The results are
summarized in Table 3. Recovery of the analytes at two levels of
concentration was consistent and reproducible. The values obtained
ranged from 99% to 111% when spiking with half of the average
concentration in serum, and ranged from 102% to 120% when spiking
with one tenth of the average concentration in serum. The results of
intra-day precision (n¼5) and inter-day precision (n¼3) range from
4 to 20%. These results showed that the method meets the standards
required for the study of hypercholesterolemia diseases.
3.7. Analysis of pooled serum
The chromatograms of the analytes in pooled serum are
showed in Fig. 4. The concentration of sterols in the pool of serum
was also determined (Table 2). It can be seen that the concentra-
tions obtained were in agreement with the values found in
literature [2,7]. As said before, serum levels of cholesterol pre-
cursors are related to liver cholesterol synthesis and they were
found in much less concentration than cholesterol in human
serum. The concentration of desmosterol and lanosterol resulted
in 0.8370.23 mg/mL and 0.1770.04 mg/mL (Table 2), similar to the
concentration values reported by McDonald et al. (0.71 mg/mL and
0.20 mg/mL, respectively) [7]. The content of phytosterols is typi-
cally higher than the content of cholesterol precursors, and it is
more sample-dependant. The concentration of stigmasterol
(1.3570.42 mg/mL), campesterol (1.4970.26 mg/mL) and sitos-
terol (1.2870.07 mg/mL) (Table 2) fall within the ranges reported
in the Human Metabolome Database [24]. Due to the association
between non-cholesterol sterols with cholesterol absorption,
synthesis and metabolism, the determination of these compounds
is a useful tool to explore their behavior in the human body.
4. Conclusions
An online SPE–LC–MS system to determine non-cholesterol
sterols in human serum has been developed and described herein.
The method allows the determination of two cholesterol precursors,
desmosterol and lanosterol, and three phytosterols, stigmasterol,
campesterol and sitosterol.
This protocol substantially reduces the sample treatment, avoid-
ing the time-consuming evaporation and reconstitution steps. The
lipoproteins were extracted using the well-established Bligh–Dyer
method, and the losses associated to a protein precipitation step
with methanol or acetonitrile were eluded. This was achieved
thanks to the careful selection of both the final extract and the
initial mobile phase solvent compositions.
Two LC instruments have been coupled to operate simulta-
neously by using event analog signals. As a consequence, no
additional tasks have to be executed by the analyst to run the
online system. The use of the C18 cartridge combined with C18 LC
was not a problem thanks to a water cross-flow added between
both stationary phases. This can be performed by using a 10-port
switching valve instead of an ordinary 6-port valve. Matrix effects
were thoroughly studied and reduced to an extent that external
standard calibration could be used.
All this work led to a sample treatment time reduction of 75%;
that is to say, using this protocol, 25 samples can be handled in
only 2 h. In previous works, the authors needed a working day
(8 h) to handle these samples, using the alternative Bligh–Dyer,
evaporation, reconstitution and SPE clean-up protocol based on
the work of McDonald et al. [8].
The significant reduction in the analysis time would help in the
research of cholesterol related diseases, which demands the proces-
sing of high number of samples to infer reliable conclusions.
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